Abstract
Introduction: Brachytherapy is a treatment in which sealed radioactive sources are used to deliver high doses of radiation at close distance to the tumor with rapid dose fall-off in the surrounding normal tissue resulting in high therapeutic ratio in oncological disease management. It is effective in palliative treatment for patients with symptoms of hemoptysis and dysnea resulting from endobronchial obstruction.
Conclusion: In spite of the rapid development of external beam radiation therapy brachytherapy continues to remain an important mode of therapy and is often a default treatment when external beam radiation option is limited.
Keywords: Lung cancer, non-small cell, brachytherapy, High Dose Rate (HRD), treatment, tumor.
Graphical Abstract
Current Cancer Therapy Reviews
Title:Lung Cancer Brachytherapy
Volume: 14 Issue: 2
Author(s): Edward Yu*Craig Lewis
Affiliation:
- Department of Oncology, Western University, Ontario, ON N6A-4L6,Canada
Keywords: Lung cancer, non-small cell, brachytherapy, High Dose Rate (HRD), treatment, tumor.
Abstract: Introduction: Brachytherapy is a treatment in which sealed radioactive sources are used to deliver high doses of radiation at close distance to the tumor with rapid dose fall-off in the surrounding normal tissue resulting in high therapeutic ratio in oncological disease management. It is effective in palliative treatment for patients with symptoms of hemoptysis and dysnea resulting from endobronchial obstruction.
Conclusion: In spite of the rapid development of external beam radiation therapy brachytherapy continues to remain an important mode of therapy and is often a default treatment when external beam radiation option is limited.
Export Options
About this article
Cite this article as:
Yu Edward *, Lewis Craig , Lung Cancer Brachytherapy, Current Cancer Therapy Reviews 2018; 14 (2) . https://dx.doi.org/10.2174/1573394714666180208145420
DOI https://dx.doi.org/10.2174/1573394714666180208145420 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-inflammatory Phytochemicals for Chemoprevention of Colon Cancer
Current Cancer Drug Targets The Role of Biomarker Genes in the Diagnosis and Treatment of Nonsmall Cell Lung Cancer
Current Respiratory Medicine Reviews Molecular Dynamics as a Tool in Rational Drug Design: Current Status and Some Major Applications
Current Computer-Aided Drug Design Clinical Applicability of Sequence Variations in Genes Related to Drug Metabolism
Current Drug Metabolism Absorption, Disposition and Pharmacokinetics of Nanoemulsions
Current Drug Metabolism Cytochrome P450 Gene Polymorphism and Cancer
Current Drug Metabolism Dendritoma Vaccine for Cancer: A Hopeful Approach
Current Cancer Therapy Reviews Regulatory Circuitries Coordinated by Transcription Factors and microRNAs at the Cornerstone of Hematopoietic Stem Cell Self-Renewal and Differentiation
Current Stem Cell Research & Therapy Significance of Various Experimental Models and Assay Techniques in Cancer Diagnosis
Mini-Reviews in Medicinal Chemistry Design, Synthesis and Studies on Novel Polymeric Prodrugs of Erlotinib for Colon Drug Delivery
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs as Tools and Effectors for Patient Treatment in Gastrointestinal Carcinogenesis
Current Drug Targets Meet Our Editors
Medicinal Chemistry Serotonin and Cancer: What Is the Link?
Current Molecular Medicine Inhibition of RAGE Axis Signaling: A Pharmacological Challenge
Current Drug Targets Chemotherapy of Chagas Disease
Current Pharmaceutical Design Radionuclide Antibody-Conjugates, a Targeted Therapy Towards Cancer
Current Radiopharmaceuticals Recent Progress on Antifungal Drug Development
Current Pharmaceutical Biotechnology Nelarabine- A New Purine Analog in the Treatment of Hematologic Malignancies
Reviews on Recent Clinical Trials Flavonoids and Linderone from Lindera oxyphylla and their Bioactivities
Combinatorial Chemistry & High Throughput Screening Iron Chelators in Medicinal Applications - Chemical Equilibrium Considerations in Pharmaceutical Activity
Current Medicinal Chemistry